Keywords: versant, hcv, assay, launched, europe, bayer, healthcare

Versant 2.0 HCV assay launched in Europe

Article | 27 November 2006

Print This

Bayer Healthcare, a division of Germany's Bayer group, and Belgian firm Innogenetics NV, have announced the European launch of their ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in